期刊文献+

帕米膦酸二钠治疗多发性骨髓瘤骨痛的临床观察 被引量:2

Observation of Pamidronate Disodium Used for the Treatment of Multiple Myeloma with Ostalgia
下载PDF
导出
摘要 目的:观察帕米膦酸二钠(博宁)对多发性骨髓瘤骨痛的临床疗效。方法:1 6例多发性骨髓瘤患者静脉点滴博宁90mg,每2周~4周1次。结果:博宁治疗组对骨痛的总有效率为87. 5 %,强痛定对照组对骨痛的总效率仅为37. 5 %。博宁无明显不良反应。结论:博宁能有效缓解多发性骨髓瘤骨痛和活动功能障碍,并能协同化疗促进缓解、降低患者的高血钙水平。 OBJECTIVE:To observe clinical efficiency of pamidronate disodium (bolin) for the treatment of multiple myeloma (MM) with ostalgia. METHODS: 16 patients with MM were given bolin 90mg for intravenous injection, once every 2~4 weeks. RESULTS: The total effective rate of bolin treatment group for ostalgia was 87.5%, but AP-237 control group was 37.5%. Bolin had no obvious adverse reactions. CONCLUSION: Bolin can effectively relieve MM with ostalgia and functional disturbance, as well as coordinating chemotherapy to relieve and decrease high calcium level of the patients.
作者 王丹 高楠
出处 《中国医院用药评价与分析》 2005年第3期168-169,共2页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 多发性骨髓瘤 骨痛 膦酸类 治疗应用 multiple myeloma ostalgia phosphonic acid treatment and application
  • 相关文献

参考文献3

  • 1张之南.血液病诊断及疗效标准[M].天津科学技术出版社,1999.172.
  • 2Hortobagyi GN, Therianlt RL, Porter L, et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases [ J ] . N Engl J Med, 1996,335(24): 1 785.
  • 3Berenson JR, Iichtenstein A, Porter I, et al. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma[J]. N Engl J Med , 1996,334:488.

共引文献21

同被引文献34

  • 1杨祚璋,许建波,曾才铭,袁涛,钱保生,张晋煜,李文忠,彭敏,李浴,栾丽.经皮穿刺椎体成形术治疗多发性骨髓瘤椎体病理性骨折的初步探讨[J].中国修复重建外科杂志,2005,19(12):1040-1041. 被引量:9
  • 2Singhal S, Mehta J, Desikan R, et al. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med, 1999, 341(21): 1565-1571.
  • 3Yeh HS, Berenson JR. Treatment for myeloma bone disease. Clin Cancer Res, 2006, 12(20P12): 6279-6284.
  • 4Rajkumar SV, Gertz MA Lacy MQ, et al. Thalidomide as initial therapy For early stage myeloma. Leukemia, 2003, 10: 375-379.
  • 5Marriott ]B, Muller G, Stirling D, et al. Immunotherapeutic and antitumour potential of thalidomide analogues. Expert Opin Biol Ther, 2001, 1(4): 675-682.
  • 6Hideskima T. Thalidomide and its analogues overcome drug resistance of human multiple myeloma cells to conventional therapy. Blood, 2000, 96(9): 2943-2950.
  • 7Weber D. Thalidomide alone or with dexamethasone for previously untreated multiple myeloma.J Clin Oncol, 2003, 21 (1): 16-19.
  • 8Kanis IA, Meclosekey EV. Bisphosphonate in multiple myeloma. Cancer, 2000, 88(S12): 3022-3032.
  • 9Raje N, Anderson KC. Introduction: the evolving role of bisphosphonate therapy in multiple myeloma. Blood, 2000, 96:381-384.
  • 10Kuzzmann V, Bauer E, Fouria J, et al. Stimulation of gammadelta T cells by aminobisphosphonate and induction of antiplasma cell activity in multiple myeloma. Blood, 2000, 96: 384-392.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部